Found: 32
Select item for more details and to access through your institution.
Preparation of 2CaO·3B<sub>2</sub>O<sub>3</sub>·H<sub>2</sub>O nanomaterials and evaluation of their flame retardant properties by a thermal analysis method.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2019, v. 135, n. 5, p. 2783, doi. 10.1007/s10973-018-7138-6
- By:
- Publication type:
- Article
In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97457-3
- By:
- Publication type:
- Article
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2023, v. 64, n. 6, p. 1, doi. 10.1093/ejcts/ezad373
- By:
- Publication type:
- Article
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 3, p. 635, doi. 10.1007/s00520-014-2405-y
- By:
- Publication type:
- Article
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229435
- By:
- Publication type:
- Article
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818
- By:
- Publication type:
- Article
KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 4, p. 1381, doi. 10.1245/s10434-012-2754-z
- By:
- Publication type:
- Article
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 267, doi. 10.1007/s10147-019-01552-5
- By:
- Publication type:
- Article
Incidence and Risk Factors of Hypoglycemia in Patients with Hepatocellular Carcinoma.
- Published in:
- Journal of Nursing (China), 2022, v. 29, n. 17, p. 43, doi. 10.16460/j.issn1008-9969.2022.17.043
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development and Validation of a <sup>18</sup>F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of Malignancy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 396, doi. 10.1002/cam4.4925
- By:
- Publication type:
- Article
Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1683
- By:
- Publication type:
- Article
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 1, p. 337, doi. 10.1002/ctm2.12
- By:
- Publication type:
- Article
Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer.
- Published in:
- Pathology & Oncology Research, 2013, v. 19, n. 4, p. 833, doi. 10.1007/s12253-013-9651-z
- By:
- Publication type:
- Article
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 11, p. 1619, doi. 10.1111/1759-7714.14429
- By:
- Publication type:
- Article
Three‐dimensional printed navigational template for localizing small pulmonary nodules: A case‐controlled study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 9, p. 2690, doi. 10.1111/1759-7714.13550
- By:
- Publication type:
- Article
Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2279, doi. 10.1111/1759-7714.13542
- By:
- Publication type:
- Article
Prophylactic air‐extraction strategy after thoracoscopic wedge resection.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 11, p. 1406, doi. 10.1111/1759-7714.12850
- By:
- Publication type:
- Article
EGFR mutations in early‐stage and advanced‐stage lung adenocarcinoma: Analysis based on large‐scale data from China.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 7, p. 814, doi. 10.1111/1759-7714.12651
- By:
- Publication type:
- Article
Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-022-01286-3
- By:
- Publication type:
- Article
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 61, doi. 10.1634/theoncologist.2016-0150
- By:
- Publication type:
- Article
Lung Cancer Treatment Disparities in China: A Question in Need of an Answer.
- Published in:
- Oncologist, 2014, v. 19, n. 10, p. 1084, doi. 10.1634/theoncologist.2014-0007
- By:
- Publication type:
- Article
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00245-y
- By:
- Publication type:
- Article
Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 2, p. 155, doi. 10.1111/1759-7714.12076
- By:
- Publication type:
- Article
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.
- Published in:
- Medical Oncology, 2012, v. 29, n. 2, p. 627, doi. 10.1007/s12032-011-9924-x
- By:
- Publication type:
- Article
Combined Cellular Automaton Model for Dynamic Recrystallization Evolution of 42CrMo Cast Steel.
- Published in:
- Chinese Journal of Mechanical Engineering, 2018, v. 31, n. 1, p. 1, doi. 10.1186/s10033-018-0284-8
- By:
- Publication type:
- Article
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung.
- Published in:
- 2014
- By:
- Publication type:
- journal article